These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6884507)

  • 1. Effects of glucose, anoxia, and adriamycin on the chemiluminescence of Ehrlich Ascites cells.
    Cheng B; Williams M; Chance B
    FEBS Lett; 1983 Aug; 160(1-2):169-72. PubMed ID: 6884507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent ineffectiveness of adriamycin for growth of androgen-dependent Shionogi carcinoma 115 in the mouse.
    Omukai Y; Watanabe S; Nohno T; Senoo T; Saito T
    Cancer Lett; 1983 Jan; 17(3):327-32. PubMed ID: 6831388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane fluidity in Ehrlich ascites tumor cells treated with adriamycin.
    Sugiyama M; Sakanashi T; Okamoto K; Chinami M; Hidaka T; Ogura R
    Biotechnol Appl Biochem; 1986; 8(2-3):217-21. PubMed ID: 3741633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of adriamycin uptake by lonidamine in Ehrlich ascites tumor cells.
    Floridi A; Gambacurta A; Bagnato A; Bianchi C; Paggi MG; Silvestrini B; Caputo A
    Exp Mol Pathol; 1988 Dec; 49(3):421-31. PubMed ID: 3197818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of resistance to adriamycin (NSC-123127) in Ehrlich ascites tumor in vivo.
    Danø K
    Cancer Chemother Rep; 1972 Jun; 56(3):321-6. PubMed ID: 19051490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive correlation between decreased cellular uptake, NADPH-glutathione reductase activity and adriamycin resistance in Ehrlich ascites tumor lines.
    Scheulen ME; Hoensch H; Kappus H; Seeber S; Schmidt CG
    Arch Toxicol; 1987; 60(1-3):154-7. PubMed ID: 3619636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of perfluorodecalin on viability of Ehrlich ascites tumor cells under conditions of hypoxia.
    Sabyrbek ZhB; Alekseeva OM; Tuleukhanov ST; Kim YA
    Bull Exp Biol Med; 2012 Jan; 152(3):353-6. PubMed ID: 22803084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glucosone on the proliferation and energy metabolism of in vitro grown Ehrlich ascites tumor cells.
    Reiffen KA; Löffler M; Schneider F
    Z Naturforsch C Biosci; 1981; 36(3-4):255-61. PubMed ID: 7245839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures to study the cytostatic effects of interferon on Ehrlich ascites cells.
    Nagano Y; Saito H
    Methods Enzymol; 1981; 79(Pt B):360-1. PubMed ID: 6173684
    [No Abstract]   [Full Text] [Related]  

  • 10. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells.
    Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A
    Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antineoplastic drugs and estradiol on leucine uptake and proliferation of Ehrlich tumor cells.
    Levin E; Cherñavsky A
    Biomed Pharmacother; 1989; 43(3):215-7. PubMed ID: 2775858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: comparison with transport in human red blood cells.
    Dalmark M; Hoffmann EK
    Scand J Clin Lab Invest; 1983 May; 43(3):241-8. PubMed ID: 6312556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
    Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
    Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice.
    Fung KP; Ng SW; Choy YM
    Cancer Biochem Biophys; 1986 Oct; 8(4):249-56. PubMed ID: 3802046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental examinations about the proliferation and radiotherapy after administration of Vincristin and Adriamycin (author's transl)].
    Esser E; Haut J; Schumann J; Wannenmacher M; Wingenfeld U
    Strahlentherapie; 1977 Oct; 153(10):682-94. PubMed ID: 919005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of natural polyamines by cadaverine and its aminopropyl derivatives in Ehrlich ascites carcinoma cells.
    Alhonen-Hongisto L; Seppänen P; Hölttä E; Jänne J
    Biochem Biophys Res Commun; 1982 May; 106(2):291-7. PubMed ID: 6809002
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of amiloride derivatives on the thermosensitivity of an adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Hiraki Y
    Anticancer Res; 1994; 14(3A):805-7. PubMed ID: 8074482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of 'in situ' mitochondrial membrane potential in Ehrlich ascites tumor cells during aerobic glycolysis.
    Sánchez Olavarría J; Galindo C; Montero M; Baquero Y; Victorica J; Satrústegui J
    Biochim Biophys Acta; 1988 Oct; 935(3):322-32. PubMed ID: 3167052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
    Sadzuka Y; Iwazaki A; Miyagishima A; Nozawa Y; Hirota S
    Jpn J Cancer Res; 1995 Jun; 86(6):594-9. PubMed ID: 7622424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of bleomycin on Ehrlich ascites carcinoma in suspension culture.
    Eells JT; Farrell LD; Fontenelle LJ
    Proc West Pharmacol Soc; 1977; 20():199-203. PubMed ID: 70790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.